Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026)

Bioventus (BVS) reported Income from Non-Controlling Interests of $833000.0 for Q1 2026, up 221.61% on a YoY basis from $259012.7 in Q1 2025, and down 67.5% quarter-over-quarter from $2.6 million in Q4 2025.

Bioventus (BVS) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Bioventus has reported Income from Non-Controlling Interests for 7 years, with the latest figure at $833000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Non-Controlling Interests rose 221.61% year-over-year to $833000.0; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 651.86% YoY), and the FY2025 full-year result was $4.5 million, changed N/A from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 stood at $833000.0, down from $2.6 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $18.5 million in Q4 2022, with the low at -$20.4 million in Q2 2023.
  • Historically, Income from Non-Controlling Interests has averaged -$765133.3 across 5 years, with a median of -$685000.0 in 2025.
  • The largest YoY upside for Income from Non-Controlling Interests was 1312.43% in 2022 against a maximum downside of 764.95% in 2022.
  • Bioventus' Income from Non-Controlling Interests stood at $18.5 million in 2022, then tumbled by 108.03% to -$1.5 million in 2023, then surged by 819.69% to $10.7 million in 2024, then plunged by 76.07% to $2.6 million in 2025, then slumped by 67.5% to $833000.0 in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $833000.0 (Q1 2026), $2.6 million (Q4 2025), and $851000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 6.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 22.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -5.85 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 100,000.00
10 Bioventus 571.68 Mn 581.20 Mn 90.77 Mn 833,000.00

Historic Data

Download Data
DateValue
Mar 28, 2026 833,000.00
Dec 31, 2025 2.56 Mn
Sep 27, 2025 851,000.00
Jun 28, 2025 1.81 Mn
Mar 29, 2025 -685,000.00
Dec 31, 2024 10.71 Mn
Sep 28, 2024 -683,000.00
Jun 29, 2024 -8.54 Mn
Mar 30, 2024 -1.49 Mn
Sep 30, 2023 -1.49 Mn
Apr 1, 2023 -20.36 Mn
Dec 31, 2022 18.54 Mn
Oct 1, 2022 -9.25 Mn
Jul 2, 2022 -762,000.00
Apr 2, 2022 -3.53 Mn
Dec 31, 2021 -1.53 Mn
Oct 2, 2021 -1.30 Mn
Jul 3, 2021 -6.65 Mn
Apr 3, 2021 -408,000.00
Dec 31, 2020 -525,000.00